London open: Markets dip on mixed earnings, ex-div stocks fall
14th May 2015 08:15
UK shares declined on Thursday morning ahead of a quiet session in terms of economic data, with corporate earnings coming in mixed and a number of ex-dividend stocks in the red. The FTSE 100 was down 0.58% at 6,909.22 early on. Global stock markets closed in a mixed fashion on Wednesday on the back
Read moreHikma Pharmaceuticals launches caffeine citrate injection
12th May 2015 13:41
Hikma Pharmaceuticals on Tuesday launched a caffeine citrate injection to treat apnea resulting from prematurity in infants of between 28 and 33 weeks of gestational age. The company noted that sales of caffeine citrate injections in the US last year were of $7.6m. Chairman and chief executive Said
Read moreLondon close: FTSE 100 books new all-time highs to close above 7000
20th Mar 2015 16:52
Dovish central banks and fading worries about Greece exiting the Eurozone propelled the London market to record fresh all-time highs on Friday. At Friday's close, the FTSE 100 index stood strong at 7022.51, up 0.8% on the day, off a touch from its session high of 7024.21. "The FTSE 100's landmark m
Read moreFTSE 250 movers: Miners higher, Debenhams weaker on downgrade
20th Mar 2015 13:45
Vedanta Resources topped the risers, despite cutting its capital expenditure budget for 2015 by $400m and halving its 2016 budget. Miners Lonmin and Kaz Minerals were making gains on the rising three-month copper futures, which were 1.5% higher. Ophir Energy was boosted as investment analysts at De
Read moreHikma Pharma shares drop on reports of the company's first benchmark bond issuance
17th Mar 2015 15:30
Middle East focused Hikma Pharmaceuticals is reportedly planning to sell its first benchmark-sized dollar bonds, according to two people familiar with the sale. Bloomberg News on Tuesday cited sources close to the deal in its report. Shares in Hikma fell 1.8% to 2217p on the back of the report, as m
Read moreThursday tips round-up: Hikma Pharmaceuticals, Foxtons
12th Mar 2015 18:16
Hikma Pharmaceuticals' decision not to sell its injectables business is probably one of the savviest decisions the company has taken in the last few years. The price-tag mooted was $2bn. More importantly, it put the little-known firm on many investors' radars. That unit saw its sales in the US rise
Read moreFTSE 250 movers: Domino Printing up on Japanese acquisition
11th Mar 2015 13:42
Japan-based office equipment supplier Brother Industries has agreed to acquire British printing technology company Domino Printing Sciences for £1.03bn, unleashing a 32% surge in the share price. Domino, which has operations in the UK, China, Germany, India, Sweden and the US, will continue to opera
Read moreHikma injects new life into annual profit, remains optimistic about 2015
11th Mar 2015 08:16
Strong performances in Hikma Pharmaceuticals' injectable drug business drove the company's annual pre-tax higher by over 20%, though a warning about the impact of the US dollar on 2015 revenues was perhaps behind an initial fall in the shares. The Jordanian drugmaker reported a 21% year-on-year incr
Read moreHika Pharma promoted to FTSE 100 but Tullow Oil gets kicked out
5th Mar 2015 15:01
Hika Pharmaceuticals and Tullow Oil are switching places at start of the second quarter of this year as the FTSE Group reshuffles components across its leading London benchmarks. In its quarterly review, the FTSE Group have outlined which companies have been promoted or demoted from its indices. The
Read moreSector movers: GSK leads defensive pharma stocks higher
4th Feb 2015 14:35
A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high. Sales, profits and earnings slumped during the fourth quarter of
Read moreHikma Pharmaceuticals hiked by court colchicine ruling
12th Jan 2015 08:08
A US court has given Hikma Pharmaceuticals permission to distribute its colchicine gout treatment, turning down rival Takeda Pharmaceuticals in its appeal for an injunction against the distribution of the drugs. The injunction, which was granted to Takeda on 9 October 2014, has been vacated followin
Read moreFTSE 250 movers: Energy sector struggles as oil price continues to slide
5th Jan 2015 14:04
Oil producers such as Afren and Premier Oil, and energy services firms Wood Group, Hunting and Petrofac, were all falling sharply on Monday as the price of oil continued to sink. Brent crude dropped below $55 a barrel (bbl) for the first time since May 2009. Afren was also continuing to decline afte
Read moreLondon midday: Resource stocks drag FTSE 100 into the red
5th Jan 2015 11:36
UK stocks were trading firmly in the red by Monday lunchtime despite a positive start, with shares in the oil and mining sectors providing a drag. London's FTSE 100 was down 0.9% at 6,489 by midday, dropping sharply after reaching a high of 6,576.74 early on. This week will be the first full tradin
Read moreHikma soars after bullish recommendation from brokers
5th Jan 2015 10:14
Hikma Pharmaceuticals shares edged closer to an all-time high on Monday, in the wake of bullish recommendation from two brokers. The stock, which rose 66.8% in 2014, was among Europe's best performing small-cap after JP Morgan lifted its price target on Hikma shares by 18.4% and maintained an 'overw
Read moreSector movers: Defensive pharma stocks fall as Santa Rally continues
23rd Dec 2014 16:18
Pharmaceutical and healthcare stocks were leading the fallers on Tuesday as investors dumped defensive assets amid a continued pre-Christmas rally. UK stocks have risen for six straight days as markets rebounded strongly following a recent sell-off. While more cyclical sectors such as construction
Read more